PharmiWeb.com - Global Pharma News & Resources
07-Sep-2023

Discovery Park welcomes decision to re-join EU Horizon science programme

Sandwich, United Kingdom, 7th September 2023 / Discovery Park, Kent’s thriving life science community, welcomes today’s announcement that the UK will re-join the EU’s Horizon science research programme. This international collaboration brings together the brightest minds in the world and offers transformational funding that will be vital to drive scientific discovery.  

Positioned in Kent at the interface of the UK and Europe, Discovery Park is home to a wide range of companies driving scientific development who will benefit from the opportunities this programme brings. Kent’s flourishing science and technology cluster will be a cornerstone of this growing international collaboration. 

Following two years of negotiations, this news demonstrates the UK’s commitment to R&D and building a strong research pipeline. This will be key to developing solutions to some of the world’s biggest challenges as well as building a strong science and technology economy in the UK.  

Mayer Schreiber, CEO of Discovery Park, commented: “We’re excited by today’s news that the UK will once again be part of Horizon Europe’s world leading research programme. Collaboration is vital to successful science and innovation and the funding and partnership opportunities the programme offers will bring considerable benefits to the UK and Europe. Nowhere is this more relevant than Kent, on the doorstep of Europe. We look forward to seeing the companies based at Discovery Park and our local universities benefit from the programme as well as welcoming new organisations to the growing Kent science and technology community.”  

ENDS

For further information, please contact

Kirsty Budden
Head of Marketing, Discovery Park
E: kirsty.budden@discovery-park.co.uk 
T: +44 (0) 7730 618514 

Sciad Communications, Media Relations 
Juliette Craggs / Jasmin Shearan
E: pressteam@sciad.com
T: +44 (0)20 3405 7892 

Notes for Editors

About Discovery Park 

Discovery Park is a thriving life science community for visionary entrepreneurs and leaders and the ideal environment for businesses to start, scale and succeed. We offer state-of-the-art labs, modern offices and manufacturing facilities, unrivalled flexibility and comprehensive support including access to finance and a strong local talent pool. Within easy reach of London, Discovery Park spearheads Kent’s flourishing science and technology cluster. As an extension of the Golden Triangle, our location provides access to a wealth of resources and opportunities coupled with an enviable quality of life.  

Discovery Park is home to 160+ companies employing around 3,500 people across a growing tenant community of dynamic start-ups through to global corporations. This includes Pfizer, which built the site’s reputation as a centre for drug discovery and discovered some of the most famous drugs in the world here. Pfizer still play a key role in the community, occupying a third of the site and employing over 1,000 scientists, technicians, regulatory professionals and business experts. Other tenants include Algaecytes, Canterbury Christ Church University, Concept Life Sciences, eXroid, Genea Biomedx, LGC, Viatris, Psyros Diagnostics, Salvensis, VisusNano and Wren Healthcare.  

Discover more via our website: www.discovery-park.co.uk email: info@discovery-park.co.uk or call: 01304 614060. You can also follow us on social media: LinkedIntwitterFacebook.   

Editor Details

Last Updated: 13-Sep-2023